EYPT
EyePoint Pharmaceuticals Inc
Price:  
8.25 
USD
Volume:  
501,703.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYPT Relative Valuation

-534.1%
Upside

As of 2024-12-12, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (35.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.25 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -534.1%.

The range of the Relative Valuation is (22.66) - (35.95) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.8x - 23.6x 22.2x
Forward P/E multiples 14.9x - 25.2x 24.9x
Fair Price (22.66) - (35.95) (35.82)
Upside -374.7% - -535.8% -534.1%
8.25 USD
Stock Price
(35.82) USD
Fair Price

EYPT Relative Valuation - Historical P/E Data

Date P/E
2024-12-11 -5.42
2024-12-10 -5.56
2024-12-09 -5.82
2024-12-06 -5.73
2024-12-05 -5.37
2024-12-04 -5.58
2024-12-03 -5.50
2024-12-02 -5.76
2024-11-29 -5.82
2024-11-27 -5.95
2024-11-26 -5.92
2024-11-25 -6.07
2024-11-22 -5.88
2024-11-21 -5.49
2024-11-20 -5.89
2024-11-19 -6.06
2024-11-18 -5.64
2024-11-15 -6.03
2024-11-14 -6.90
2024-11-13 -7.07
2024-11-12 -7.31
2024-11-11 -7.89
2024-11-08 -7.65
2024-11-07 -7.62
2024-11-06 -7.94
2024-11-05 -7.63
2024-11-04 -7.69
2024-11-01 -7.93
2024-10-31 -7.73
2024-10-30 -7.54
2024-10-29 -7.59
2024-10-28 -7.97
2024-10-25 -6.25
2024-10-24 -6.29
2024-10-23 -6.55
2024-10-22 -7.07
2024-10-21 -7.04
2024-10-18 -7.27
2024-10-17 -7.33
2024-10-16 -7.42
2024-10-15 -6.50
2024-10-14 -6.69
2024-10-11 -5.81
2024-10-10 -5.42
2024-10-09 -5.52
2024-10-08 -5.58
2024-10-07 -5.73
2024-10-04 -5.67
2024-10-03 -5.50
2024-10-02 -5.40